Table 1.
Clinical and molecular characteristics of patients according to EBER.
| Characteristics | EBER | P-value | |
|---|---|---|---|
| Negative | Positive | ||
| All cases | 1273 | 55 | |
| Age | 0.017 | ||
| <=60 | 647(94.60%) | 37(5.40%) | |
| >60 | 626(97.20%) | 18(2.80%) | |
| Gender | 0.174 | ||
| Female | 336(97.10%) | 10(2.90%) | |
| Male | 937(95.40%) | 45(4.60%) | |
| Lauren type | 0.101 | ||
| Diffuse | 297(95.80%) | 13(4.20%) | |
| Intestinal | 720(96.40%) | 27(3.60%) | |
| Mixed | 200(93.00%) | 15(7.00%) | |
| Differentiation | 0.004 | ||
| Poor | 581(93.70%) | 38(6.30%) | |
| Moderate | 584(97.30%) | 16(2.70%) | |
| Well-differentiated | 31(100.00%) | 0(0.00%) | |
| Tumor size | 0.966 | ||
| <5cm | 657(95.60%) | 30(4.40%) | |
| >=5cm | 554(95.70%) | 25(4.30%) | |
| Vascular invasion | 0.034 | ||
| Negative | 605(94.50%) | 35(5.50%) | |
| Positive | 630(96.90%) | 20(3.10%) | |
| Histological type | 0.029 | ||
| Adenocarcinoma | 1158(95.50%) | 55(4.50%) | |
| Signet ring cell carcinoma | 101(100.00%) | 0(0.00%) | |
| pTNM | 0.259 | ||
| 0 | 1(100.00%) | 0(0.00%) | |
| 1 | 139(97.90%) | 3(2.10%) | |
| 2 | 361(94.50%) | 21(5.00%) | |
| 3 | 600(95.40%) | 29(4.60%) | |
| 4 | 109(98.20%) | 2(1.80%) | |
| PCNA | 0.180 | ||
| 1 | 40(100.00%) | 0(0.00%) | |
| 2 | 140(97.20%) | 4(2.80%) | |
| 3 | 907(95.00%) | 48(5.00%) | |